Trial
Dr Hope S. Rugo Discusses Clinical Trial Minority Recruitment, PALOMA-2 Findings
[ad_1]
Hope S. Rugo, MD, FASCO, is professor of medicine and the director of the Breast Oncology and Clinical Trials Education program at the Uni...
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
[ad_1]
1. A double-blinded, randomized controlled trial found that varenicline significantly improved the rate of abstinence from smoking in Afr...
Breast Cancer Trial Looks to Recruit Underserved Communities : Oncology Times
[ad_1]
health disparities:
health disparities
Since the beginning of the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) in 2017, ...
Clinical Trial Diversity
[ad_1]
Clinical trials are an essential component of health care. They help ensure that new medicines or treatments are safe and effective, and t...
Food to Overcome Outcomes Disparities: A Randomized Controlled Trial of Food Insecurity Interventions to Improve Cancer Outcomes
[ad_1]
Abstract
Food insecurity is prevalent among low-income immigrant and minority patients with cancer. To our knowledge, this randomized ...
Effectiveness of a COVID-19 Testing Outreach Intervention for Latinx Communities: A Cluster Randomized Trial | Health Disparities | JAMA Network Open
[ad_1]
Key Points
Question
Can a culturally informed community-based outreach intervention increase Latinx participation a...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
